Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Sanofi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.

Sanofi

Developing a COVID-19 vaccine

Developing a COVID-19 vaccine French drugmaker Sanofi also currently has two ongoing collaborations to develop a COVID-19 vaccine candidate.

As COVID-19 takes over the world, biopharma fights back

As COVID-19 takes over the world, biopharma fights back Evaluating IL-6 inhibitors: Roche’s Actemra and Sanofi and Regeneron’s Kevzara. Roche, Sanofi and Regeneron are also looking to repurpose their existing treatments and are currently testing their ... Encouraged by this initial data, Sanofi and

Start small but think big

Start small but think big Exploring the potential of agility in unlocking creativity. When Sanofi US issued a witty retort to Roseanne Barr’s tweet alleging that it was one of Sanofi’s treatments that had ... Sanofi’s tweet felt innovative because it connected and responded

J&J says COVID-19 vaccine could be ready in early 2021

J&J says COVID-19 vaccine could be ready in early 2021 J&J joins companies including Sanofi, GlaxoSmithKline, Pfizer and others in preparing for trials of COVID-19 vaccines, but at the moment US biotech Moderna is out in front, having dosed

Sanofi doses first patient in global Kevzara COVID-19 trial

Sanofi doses first patient in global Kevzara COVID-19 trial Sanofi is leading trials outside the US while Regeneron is leading US trials. ... global health crisis,” said John Reed, global head of research and development at Sanofi.

[ Previous 5 results ] 13 14 15 16 17 18 19 20 21 22 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics